Evidence map›Paper›PMID 40408054›Full record

ArticleIn vitro cellular & developmental biology. Animal2025

Synergistic effects of micropatterned substrates and transforming growth factor-β1 on differentiation of human mesenchymal stem cells into vascular smooth muscle cells through modulation of Krϋppel-like factor 4.

Sakhavat Abolhasani, Davood Fattahi, Yasin Ahmadi, Behnaz Valipour, Majid Ghasemian, Masoumeh Rajabibazl, Khalil Maleki Chollou

Abstract read
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sakhavat AbolhasaniDepartment of Basic Sciences and Health, Sarab Faculty of Medical Sciences, Sarab, East Azerbaijan, Iran. bio.sakhi@gmail.com.ORCID http://orcid.org/0000-0001-9888-7508
Davood FattahiSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool, L3 3AF, UK. m.d.fattahi@2024.ljmu.ac.uk.ORCID http://orcid.org/0000-0002-5785-466X
Yasin AhmadiDepartment of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Chamran Highway, Tehran, Iran.ORCID http://orcid.org/0000-0001-6721-1775
Behnaz ValipourDepartment of Basic Sciences and Health, Sarab Faculty of Medical Sciences, Sarab, East Azerbaijan, Iran.ORCID http://orcid.org/0000-0002-0273-9576
Majid GhasemianDepartment of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Chamran Highway, Tehran, Iran.ORCID http://orcid.org/0000-0003-2017-7877
Masoumeh RajabibazlDepartment of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Chamran Highway, Tehran, Iran. Rajabi_m@sbmu.ac.ir.ORCID http://orcid.org/0000-0002-9720-5904
Khalil Maleki ChollouDepartment of Basic Sciences and Health, Sarab Faculty of Medical Sciences, Sarab, East Azerbaijan, Iran.ORCID http://orcid.org/0000-0002-6810-520X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The functionality and structural integrity of the cardiovascular system are critically dependent on vascular smooth muscle cells (VSMCs). Human mesenchymal stem cells (hMSCs) have significant potential for differentiating into VSMCs, making them a valuable resource in regenerative medicine and the development of vascular grafts. This study explored the synergistic effects of micropatterned substrates and TGF-β1 on the differentiation of hMSCs into VSMCs. HMSCs were cultured on both micropatterned and flat substrates for a duration of 6 days, with some groups receiving TGF-β1 treatment, after which cell morphology and the expression of specific smooth muscle markers were evaluated through Western blotting, immunofluorescence staining, and RT-qPCR. Results indicated that hMSCs on micropatterned substrates treated with TGF-β1 exhibited significantly elevated protein levels of smooth muscle myosin heavy chain (MYH11) compared with hMSCs on flat substrates without TGF-β1 (p < 0.001). Additionally, MYH11 expression was markedly enhanced in samples cultured on micropatterned substrates with TGF-β1. Furthermore, hMSCs treated with TGF-β1 on flat substrates exhibited increased cadherin-11 mRNA expression compared with both micropatterned and flat substrates lacking TGF-β1 (p < 0.05). Interestingly, KLF4 protein levels were significantly higher in hMSCs on flat substrates without TGF-β1 compared to those cultured on micropatterned substrates with TGF-β1 treatment (p < 0.001). In conclusion, this study demonstrated that the combination of micropatterned substrates and TGF-β1 treatment preferentially enhances MYH11 expression, indicative of advanced smooth muscle cell organization, along with modulating KLF4 levels and upregulating cadherin-11 expression in hMSCs. These findings provide critical insights into the differentiation pathways of MSCs into VSMCs and may inform the design of improved vascular grafts that better replicate the properties of native blood vessels.

Indexed as

Cell DifferentiationKruppel-Like Transcription FactorsMesenchymal Stem CellsMuscle, Smooth, VascularMyocytes, Smooth MuscleTransforming Growth Factor beta1CadherinsGene Expression RegulationHumansKruppel-Like Factor 4Myosin Heavy ChainsCadherinsKLF4 protein, humanKruppel-Like Factor 4Kruppel-Like Transcription FactorsMYH11 protein, humanMyosin Heavy ChainsTransforming Growth Factor beta1Human mesenchymal stem cellsKrϋppel-like factor 4Micropatterned substratesMyosin heavy chain (MYH11)Vascular smooth muscle cells

Identifiers

PMID40408054
PMCPMC12307518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.